Immunocore develops biological medicines that harness soluble T‑cell receptor technology to target d Sign up to read more
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| NATIONAL CITY NOMINEES LIMITED CITIGROUP CENTRE CANADA SQUARE CANARY WHARF LONDON E14 5LECORP | ORDINARY | 43,861,622 | 82.3% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 |
Companies with the most similar business descriptions.
Accounts not filed
| 888888 |
| 8888 |
4 more shareholders on file , sign up free to see.